![](/img/cover-not-exists.png)
COMBINATION OF ASA WITH DABIGATRAN OR RIVAROXABAN INCREASES RISK OF BLEEDING WITHOUT ADDITIONAL BENEFIT OF STROKE REDUCTION IN PATIENTS WITH ATRIAL FIBRILLATION
Strunets, Anton, Mirza, Mahek, Cho, Chi, Sra, Jasbir, Jahangir, ArshadVolume:
63
Language:
english
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/S0735-1097(14)60440-X
Date:
April, 2014
File:
PDF, 966 KB
english, 2014